Işık, Mehtap http://orcid.org/0000-0002-6789-952X
Bergazin, Teresa Danielle http://orcid.org/0000-0002-0573-6178
Fox, Thomas http://orcid.org/0000-0002-1054-4701
Rizzi, Andrea http://orcid.org/0000-0001-7693-2013
Chodera, John D. http://orcid.org/0000-0003-0542-119X
Mobley, David L. http://orcid.org/0000-0002-1083-5533
Funding for this research was provided by:
National Institute of General Medical Sciences (R01GM124270)
Article History
Received: 7 November 2019
Accepted: 24 January 2020
First Online: 27 February 2020
Compliance with ethical standards
:
: JDC was a member of the Scientific Advisory Board for Schrödinger, LLC during part of this study. JDC and DLM are current members of the Scientific Advisory Board of OpenEye Scientific Software, and DLM is an Open Science Fellow with Silicon Therapeutics. The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Vir Biotechnology, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, XtalPi, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, The Einstein Foundation, and the Sloan Kettering Institute. A complete list of funding can be found at .